Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes Roberto TrevisanMatteo ContiStefano Ciardullo Review Open access 29 April 2024
ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes Jingfang ChenQi FengZhangsuo Liu Article 27 April 2024
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials Sofia Sterner IsakssonHenrik ImbergMarcus Lind Article Open access 26 April 2024
Exercise-induced increase in muscle insulin sensitivity in men is amplified when assessed using a meal test Christian T. VoldstedlundKim A. SjøbergErik A. Richter Article Open access 25 April 2024
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes Guy S. TaylorKieran SmithLee D. Roberts Article Open access 25 April 2024
Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study Christian J. BrakenridgeAnnemarie KosterDavid W. Dunstan Article Open access 24 April 2024
Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18F-FDG-PET/MRI Jan W. ErikssonMaria J. PereiraHåkan Ahlström Article Open access 24 April 2024
Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus Sara DenicolòVera ReinstadlerGert Mayer Article Open access 22 April 2024
Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial Ji Yoon KimSang-Man JinJae Hyeon Kim Article 19 April 2024
Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial Ji Yoon KimSang-Man JinJae Hyeon Kim Article 18 April 2024
A 3D atlas of the human developing pancreas to explore progenitor proliferation and differentiation Adrian VillalbaYorick GittonRaphaël Scharfmann Article Open access 17 April 2024 Pages: 1066 - 1078
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities Simona SaccoMatteo FoschiMichele Romoli Review Open access 16 April 2024
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes Xinyu LiLouise A. DonnellyTalitha Feenstra Article Open access 16 April 2024
Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden Johanna MetsäläKari RisnesEero Kajantie Article Open access 13 April 2024
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials Thomas KaragiannisKonstantinos MalandrisEleni Bekiari Article Open access 13 April 2024
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database Aikaterini EleftheriadouDavid RileyUazman Alam Article Open access 08 April 2024
Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England Jonathan ValabhjiNaomi HolmanKetan Dhatariya Article Open access 08 April 2024
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology Aleksey MatveyenkoAdrian Vella Letter 06 April 2024
Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy Eva Sierra‑SilvestreRicardo J. AndradeMichel W. Coppieters Correction Open access 05 April 2024
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology. Reply to Matveyenko A, Vella A [letter] Nikhil R. GandasiPatrik Rorsman Letter 05 April 2024
Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring Yaxin WangSiwan LiJian Zhou Article Open access 03 April 2024
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study Cong XiePeter IrogaTongzhi Wu Article Open access 01 April 2024
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial Ditte S. KornumDavide BertoliAsbjørn M. Drewes Article Open access 28 March 2024 Pages: 1122 - 1137
Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial Elske L. van den BurgMarjolein P. SchoonakkerHanno Pijl Article Open access 28 March 2024
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults M. Loredana MarcovecchioA. Emile J. Hendrikson behalf of the INNODIA consortium Article Open access 22 March 2024 Pages: 995 - 1008
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity Vanessa YuFiona YongSteven J. Millership Article Open access 21 March 2024 Pages: 1079 - 1094
Effectiveness and safety of empagliflozin: final results from the EMPRISE study Phyo T. HtooHelen TesfayeElisabetta Patorno Article 21 March 2024
CK2 activity is crucial for proper glucagon expression Emmanuel AmpofoMandy PackClaudia Götz Extended Article Open access 20 March 2024
No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts Nicolai A. Lund-BlixAnne A. BjerregaardLars C. Stene Short Communication Open access 19 March 2024 Pages: 1023 - 1028
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort Lauren V. TurnerMartin Chase Marakfor the T1DEXI Study Group Article 19 March 2024 Pages: 1009 - 1022
Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes Dakota GustafsonPeter V. DiStefanoJason E. Fish Article Open access 15 March 2024 Pages: 1138 - 1154
A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial Alistair J. MonteyneKaja FalkenhainJonathan P. Little Short Communication Open access 14 March 2024 Pages: 1107 - 1113
Relationship of device measured physical activity type and posture with cardiometabolic health markers: pooled dose–response associations from the Prospective Physical Activity, Sitting and Sleep Consortium Matthew N. AhmadiJoanna M. BlodgettEmmanuel Stamatakis Article Open access 13 March 2024 Pages: 1051 - 1065
Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study Franziska G. RauscherTobias ElzeMengyu Wang Article Open access 02 March 2024 Pages: 928 - 939
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter] Merel M. RuissenEwout W. SteyerbergJacob K. Sont Letter 01 March 2024 Pages: 956 - 957
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention Frans PouwerSonya Deschênes Letter 01 March 2024 Pages: 954 - 955
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals Rui SheTommi SuvitaivalUlrik Pedersen-Bjergaard Article Open access 01 March 2024 Pages: 1095 - 1106
Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study Sirimon ReutrakulJason C. ParkErin C. Hanlon Short Communication 27 February 2024 Pages: 1114 - 1121
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment Mengqi SuYilin HouCong Chen Article Open access 27 February 2024 Pages: 850 - 863
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank Qiao JinEric S. H. Lauon behalf of the Hong Kong Diabetes Biobank Study Group Article Open access 27 February 2024 Pages: 837 - 849
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Rosa M. Sánchez-HernándezAna M. Wägner Letter 26 February 2024 Pages: 952 - 953
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes Alexandra Coomans de BrachèneMaria Ines AlvelosDecio L. Eizirik Extended Article 26 February 2024 Pages: 908 - 927
Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people Carolin T. LehnerMarian EberlStefanie J. Klug Article Open access 26 February 2024 Pages: 1040 - 1050
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study Jonne G. ter BraakeKelly J. Fleetwoodon behalf of the Scottish Diabetes Research Network Epidemiology Group Article Open access 26 February 2024 Pages: 1029 - 1039
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research Jeremy Basset‑SagarminagaTineke van de WeijerVera Schrauwen‑Hinderling Correction 23 February 2024 Pages: 958 - 958
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study Jimmy CélindMaria BygdellJenny M. Kindblom Article Open access 22 February 2024 Pages: 874 - 884
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes Pedro CardosoKatie G. Youngon behalf of the MASTERMIND consortium Article Open access 22 February 2024 Pages: 822 - 836
